腸管LGR4シグナル伝達は、マウス肝線維症における細菌の転移、肝内微生物叢の組成、およびI型インターフェロンの発現を変化させる

Liver fibrosis (LF) is linked to decreased type 1 interferon (IFN1) levels at steady-state, intestinal dysbacteriosis, leaky gut, and intestinal bacterial translocation. Liver leucine-rich repeats containing G protein-coupled receptor 4 (LGR4) signalling drives LF development, and intestinal LGR4 homeostasis maintains the intestinal stem cells. To explore the role of intestinal LGR4 signalling in LF and possible relationships with intrahepatic microbiota and IFN1, intraperitoneal injection of carbon tetrachloride (CCL4) was applied to induce LF in adult C57BL/6J mice with or without conditional knockout (cKO) of Lgr4 in intestinal epithelial cells (IECs). Fibrotic mice were simultaneously treated with intragastric bacteria as needed. Results showed that wild-type murine LF resulted in intestinal LGR4 reduction, increased intestinal permeability and bacterial translocation, decreased intrahepatic IFN1 levels, and decreased abundance of bacterial genera Lactobacillus, Dubosiella, and Bifidobacterium. Lgr4 cKO in IECs significantly promoted LF accompanied by increased intrahepatic abundance of genera Escherichia-Shigella, Klebsiella, Acinetobacter and decreased intrahepatic abundance of Lactobacillus, Dubosiella, and Bifidobacterium. In the absence of CCL4 challenge, Lgr4 cKO in IECs also resulted in increased intrahepatic Escherichia-Shigella and decreased Lactobacillus. In mice with Lgr4 cKO in IECs, intragastric administration of Lactobacillus significantly attenuated LF accompanied by significantly decreased intrahepatic Escherichia-Shigella, Klebsiella, and Acinetobacter along with increased intrahepatic Lactobacillus and IFN1 levels; however, deletion of the organismal IFN1 receptor abolished the Lactobacillus-mediated alleviation of LF. Co-culture of DC2.4 cells with Lactobacillus or its genomic DNA increased supernatant IFN-β levels. Overall, this study demonstrates that weakened intestinal LGR4 signalling facilitates LF by increasing intestinal permeability, altering intrahepatic microbiota composition, and decreasing liver IFN1 levels.